Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Telephone management of anticoagulation treatment works; FDA wants to change rules to expand experimental drug availability; Aprotinin injection labeling revised; FDA warns of safety concern with rituximab; FDA approves novel device for brain damage in infants; Pfizer ends phase 3 torcetrapib/atorvastatin trial

News Briefs